Anzupgo
Delgocitinib · LEO Pharma, Inc
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Anzupgo ingredients
| Active ingredient | Strength |
|---|---|
| Delgocitinib | 20 mg/g |
What Anzupgo is used for
Anzupgo is a cancer medicine (janus kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Anzupgo
- Generic name
- Delgocitinib
- Made by
- LEO Pharma, Inc
- Forms
- Cream
- Given
- Topical
- Drug class
- Janus Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA219155
- On the US market since
- 2025
Official information
- Anzupgo prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Delgocitinib)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Anzupgo?
Anzupgo (Delgocitinib) is a cancer medicine made by LEO Pharma, Inc, approved by the US FDA.
What are the ingredients of Anzupgo?
Anzupgo contains Delgocitinib (20 mg/g).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA